Pfizer Extends Long-Term Incentive Grants for Employee Retention

Details

The modifications, aimed at retaining key talent and aligning executive interests with shareholder value, extend the terms of the grants by two years. Eligible employees, including named executive officers, can elect to modify their awards. Pfizer will initiate a tender offer to facilitate the modifications, with details to be provided in related materials. This action follows Pfizer's efforts to ensure long-term performance and stock price recovery, especially in light of the COVID-19 pandemic's impact.

Items reported

Exhibits (2)

About Pfizer Inc.

Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation, recognized for its role in the research, development, and manufacturing of healthcare products. Operating in the health sector, Pfizer focuses on creating innovative medicines and vaccines that significantly improve patients' lives. It is renowned for its contributions to pivotal health areas, such as oncology, immunology, cardiovascular health, and rare diseases. Pfizer maintains a robust pipeline of products at various stages of clinical development, enhancing its market position and impact. The company is instrumental in the global pharmaceutical landscape, contributing to public health with breakthroughs like vaccines and therapies that tackle some of the world's most challenging diseases. Headquartered in New York City, Pfizer plays a critical role in addressing urgent medical needs worldwide and is involved in extensive collaborations with scientific communities and healthcare systems. As a key player in the pharmaceutical industry, Pfizer’s developments and strategic initiatives can influence market trends and health policies, underscoring its importance in the global effort to combat health issues.